top of page
Jing Jing Li is an Associate Professor at Monash University’s Centre for Health Economics, where she leads the Health Technology Assessment (HTA) Research Team.
Her expertise spans quantitative and qualitative evaluations of HTA policy and committee decision-making, economic evaluation alongside clinical trials, advanced decision-analytic modelling, demand and supply analysis, and the measurement and use of patient-reported outcomes and experience data in HTA.
Jing Jing has authored over 160 HTA reports that have shaped reimbursement and regulatory decisions in Australia and internationally. Her work supports committees such as PBAC, MSAC, ATAGI and Singapore’s ACE, and spans pharmaceuticals, vaccines, medical devices and services.
She also co-authored the world’s first ethics and evaluation framework for disability supports under the National Disability Insurance Scheme (NDIS).
bottom of page